ribavirin has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, HJ; Hsiao, NW; Hsu, YC; Huang, YT; Kao, YH; Lin, JT; Liu, YY; Wu, CY; Wu, MS | 1 |
| Ho, HJ; Hsu, YC; Huang, YT; Lin, JT; Wang, HH; Wu, CY; Wu, MS | 1 |
1 trial(s) available for ribavirin and Acute Coronary Syndrome
| Article | Year |
|---|---|
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome | 2014 |
1 other study(ies) available for ribavirin and Acute Coronary Syndrome
| Article | Year |
|---|---|
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
Topics: Acute Coronary Syndrome; Adult; Antiviral Agents; Autoimmune Diseases; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Stroke; Treatment Outcome | 2015 |